SFRP2 and colorectal cancer: Indeed, the Wnt/β-catenin pathway is constitutively active in most colorectal cancers [27], where the loss of function mutation and/or epigenetic silencing of negative regulators like APC, AXIN2, DKK1, or SFRP2 are common facts [59].